Humacyte Inc Stock (HUMA) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 153.20%1.03 | 0.41 | 0.50 | 0.47 | 0.75 |
| Cost Of Revenue | 16.08%1.43 | 1.23 | 2.04 | 9.08 | 0.26 |
22.27%14.10 | 18.14 | 19.46 | 14.61 | - | |
| Research and Development | 22.27%14.10 | 18.14 | 19.46 | 14.61 | - |
| Costs And Expenses | 10.42%24.55 | 27.40 | 29.43 | 31.30 | 25.14 |
| Operating Income/Loss | 12.88%-23.52 | -27.00 | -28.94 | -30.84 | -24.39 |
| Nonoperating Income/Loss | 181.39%7.98 | -9.81 | 11.32 | 6.03 | 6.88 |
| Income Tax Expense/Benefit | - | - | - | - | - |
57.78%-15.54 | -36.80 | -17.62 | -24.80 | -17.51 | |
| Attributable To Parent | 57.78%-15.54 | -36.80 | -17.62 | -24.80 | -17.51 |
| Basic Average Shares | 18.62%277.80 | 234.18 | 197.85 | - | 158.31 |
| Diluted Average Shares | 18.62%277.80 | 234.18 | 197.85 | - | 158.31 |
| Basic Earnings Per Share | 62.50%-0.06 | -0.16 | -0.09 | - | -0.11 |
| Diluted Earnings Per Share | 62.50%-0.06 | -0.16 | -0.09 | - | -0.11 |